Although patients in the LITE group had reduced cardiac mortality compared with patients in the control group over the 2 years of follow-up ( 7.5 % and 17.7 % , respectively ; P = 0.003 ) , there was no significant difference in cardiac mortality between patients in the PLUS group and the control group .